The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) closed the day trading at $25.03 down -2.23% from the previous closing price of $25.60. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 0.56 million shares were traded. KNSA stock price reached its highest trading level at $25.84 during the session, while it also had its lowest trading level at $24.85.
Ratios:
For a better understanding of KNSA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.77. For the most recent quarter (mrq), Quick Ratio is recorded 3.43 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On September 13, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.Wells Fargo initiated its Overweight rating on May 03, 2024, with a $34 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 09 ’25 when Patel Sanj K sold 6,029 shares for $27.05 per share. The transaction valued at 163,084 led to the insider holds 96,674 shares of the business.
Patel Sanj K sold 1,965 shares of KNSA for $53,055 on May 07 ’25. The CHAIRMAN & CEO now owns 96,674 shares after completing the transaction at $27.00 per share. On May 08 ’25, another insider, Patel Sanj K, who serves as the CHAIRMAN & CEO of the company, sold 101 shares for $27.00 each. As a result, the insider received 2,727 and left with 96,674 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 1826464128 and an Enterprise Value of 1568038272. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.80 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 3.259 whereas that against EBITDA is -110.208.
Stock Price History:
The Beta on a monthly basis for KNSA is 0.03, which has changed by 0.24465442 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, KNSA has reached a high of $28.56, while it has fallen to a 52-week low of $17.38. The 50-Day Moving Average of the stock is 9.97%, while the 200-Day Moving Average is calculated to be 9.93%.
Shares Statistics:
Over the past 3-months, KNSA traded about 653.33K shares per day on average, while over the past 10 days, KNSA traded about 525140 shares per day. A total of 42.16M shares are outstanding, with a floating share count of 39.70M. Insiders hold about 45.59% of the company’s shares, while institutions hold 56.42% stake in the company. Shares short for KNSA as of 1745971200 were 3326674 with a Short Ratio of 5.09, compared to 1743379200 on 3129716. Therefore, it implies a Short% of Shares Outstanding of 3326674 and a Short% of Float of 8.540000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
